How does HTLV-1 cause adult T-cell leukaemia/lymphoma (ATL)?

Current Opinion in Virology

Volumn 14, Issue , 2015, Pages 93-100

  Bangham, Charles R M ^a   Ratner, Lee ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOGENESIS; CLONAL VARIATION; DISEASE COURSE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN T-LYMPHOTROPIC VIRUS 1; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T CELL LEUKEMIA; T LYMPHOCYTE; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

HOST-PATHOGEN INTERACTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL;

EID: 84942509244     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2015.09.004     Document Type: Review

References (86)

1. M. Matsuoka, and K.-T. Jeang Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation Nat Rev Cancer 7 2007 270 280
2. K.S. Jones, S. Lambert, M. Bouttieer, L. Benit, F.W. Ruscetti, O. Hermine, and C. Pique Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors Viruses 3 2011 794 810
3. M.D. Lairmore, R. Anupam, N. Bowden, R. Haines, R.A. Haynes, L. Ratner, and P.L. Green Molecular determinants of human T-lymphotropic virus type 1 transmission and spread Viruses 3 2011 1131 1165
4. C.A. Pise-Masison, M.Fd. Castro-Amarante, Y. Enose-Akahata, R.C. Buchmann, C. Fenizia, P.R. Washington, D. Edwards, M. Fiocchi, L.C. Alcantara, I. Bialuk, and et al. Co-dependent of HTLV-1 p12 and p8 function in virus persistence PLoS Pathog 10 2014 e1004454
5. V.W. Valeri, A. Hryniewicz, V. Andresen, K. Jones, C. Fenizia, I. Bialuk, H.K. Chung, R. Fukumoto, R.W. Parks, M.G. Ferrari, and et al. Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits Blood 116 2013 3809 3817
6. X.T. Bai, and C. Nicot Overview on HTLV-1 p12, p8, p30, p13: accomplices in persistent infection and viral pathogenesis Front Microbiol 3 2012 400
7. N.V. Prooyen, H. Gold, V. Andresen, O. Schwartz, K. Jones, F. Ruscetti, and et al. Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission Proc Natl Acad Sci U S A 107 2010 20738 20743
8. M.M. Romeo, B. Koa, J. Kim, R. Bradyu, H.C. Healtley, J. He, C.K. Harrod, B. Barnett, L. Ratner, M.D. Lairmore, and et al. Acetylation of the c-MYC oncoprotein is required for cooperation with the HTLV-1 p30II accessory protein and the induction of oncogenic cellular transformation by p30II/c-MYC Virology 475 2015 271 288
9. T. Zhao, and M. Matsuoka HBZ and its roles in HTLV-1 oncogenesis Front Microbiol 3 2012 247
10. R.R. McKendall Neurologic disease due to HTLV-1 infection Handb Clin Neurol 123 2014 507 530
11. K. Kamoi, and M. Mochizuki HTLV infection and the eye Curr Opin Ophthalmol 23 2012 557 561
12. K. Ohshima Pathological features of diseases associated with human T-cell leukemia virus type I Cancer Sci 98 2007 772 776
13. L.B. Cook, M. Elemans, A.G. Rowan, and B. Asquith HTLV-1: persistence and pathogenesis Virology 435 2013 131 140
14. K. Ishitsuka, and K. Tamura Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma Lancet Oncol 15 2014 e517 e526
15. H. ElHajj, M. El-Sabban, H. Hasegawa, G. Zaatari, J. Ablain, S.T. Saab, A. Janin, R. Mahfouz, R. Nasr, Y. Kfoury, and et al. Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia J Exp Med 207 2010 2785 2792
16. H. ElHajj, K. Khalili, B. Ghandour, R. Nasr, S. Shahine, A. Ghantous, R. Abdel-Samad, A. Sinjab, H. Hasegawa, M. Jabbour, and et al. Preclinical efficacy of the synthetic retinoid ST1926 for treating adult T-cell leukemia/lymphoma Blood 124 2014 2072 2080
17. J. Tatsuro, T. Ishida, S. Takemoto, and et al. Randomized Phase II Study of Mogamulizumab (KW-0761) Plus VCAP-AMP-VECP (mLSG15) versus mLSG15 Alone for Newly Diagnosed Aggressive Adult T-cell Leukemia-Lymphoma (ATL) 2013 ASCO Chicago
18. C. Journo, and R. Mahieux HTLV-1 and innate immunity Viruses 3 2011 1374 1394
19. K. Fujihara, Y. Itoyama, F. Yu, C. Kubo, and I. Goto Cellular immune surveillance against HTLV-I infected T lymphocytes in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) J Neurol Sci 105 1991 99 107
20. M. Saito, V.M. Braud, P. Goon, E. Hanon, G.P. Taylor, A. Saito, N. Eiraku, Y. Tanaka, K. Usuku, J.N. Weber, and et al. Low frequency of CD94/NKG2A+T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers Blood 102 2003 577 584
21. S. Tattermusch, J.A. Skinner, D. Chaussabel, J. Banchereau, M.P. Berry, F.W. McNab, A. O'Garra, G.P. Taylor, and C.R.M. Bangham Systems biology approaches reveal a specific IFN-inducible signature in HTLV-1 associated myelopathy PLoS Pathog 8 2012 e1002480
22. F. Yu, Y. Itoyama, K. Fujihara, and I. Goto Natural killer (NK) cells in HTLV-I-associated myelopathy/tropical spastic paraparesis-decrease in NK cell subset populations and activity in HTLV-I seropositive individuals J Neuroimmunol 33 1991 121 128
23. S. Kinpara, A. Hasegawa, A. Utsunomiya, H. Nishitsuji, H. Furukawa, T. Masuda, and M. Kannagi Stromal cell-mediated suppression of human T-cell leukemia virus type 1 expression in vitro and in vivo by type I interferon J Virol 83 2009 5101 5108
24. E. Hanon, P. Goon, G.P. Taylor, H. Hasegawa, Y. Tanaka, J.N. Weber, and C.R. Bangham High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells Blood 98 2001 721 726
25. A. Bazarbachi, Y. Plumelle, J. Carlos Ramos, P. Tortevoye, Z. Otrock, G. Taylor, A. Gessain, W. Harrington, G. Panelatti, and O. Hermine Meta-analysis on the use of zidovudine and interferon-alpha in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes J Clin Oncol 28 2010 4177 4183
26. M. Hisada, E.M. Maloney, T. Sawada, W.J. Miley, P. Palmer, B. Hanchard, J.J. Goedert, and A. Manns Virus markers associated with vertical transmission of human T lymphotropic virus type 1 in Jamaica Clin Infect Dis 34 2002 1551 1557
27. C.R. Bangham, and M. Osame Cellular immune response to HTLV-1 Oncogene 24 2005 6035 6046
28. S. Jacobson Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease J Infect Dis 186 Suppl. 2 2002 S187 S192
29. S. Jacobson, H. Shida, D.E. McFarlin, A.S. Fauci, and S. Koenig Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease Nature 348 1990 245 248
30. C.R. Bangham CTL quality and the control of human retroviral infections Eur J Immunol 39 2009 1700 1712
31. K.J. Jeffery, A.A. Siddiqui, M. Bunce, A.L. Lloyd, A.M. Vine, A.D. Witkover, S. Izumo, K. Usuku, K.I. Welsh, M. Osame, and et al. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection J Immunol 165 2000 7278 7284
32. K.J. Jeffery, K. Usuku, S.E. Hall, W. Matsumoto, G.P. Taylor, J. Procter, M. Bunce, G.S. Ogg, K.I. Welsh, J.N. Weber, and et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy Proc Natl Acad Sci U S A 96 1999 3848 3853
33. N.K. Seich al Basatena, A. MacNamara, A.M. Vine, C.L. Thio, J. Astemborski, K. Usuku, M. Osame, G.D. Kirk, S.M. Donfield, J.J. Goedert, and et al. KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection PLoS Pathog 7 2011 e1002270
34. A. MacNamara, A. Rowan, S. Hilburn, U. Kadolsky, H. Fujiwara, K. Suemori, M. Yasukawa, G. Taylor, C.R. Bangham, and B. Asquith HLA class I binding of HBZ determines outcome in HTLV-1 infection PLoS Pathog 6 2010 e1001117
35. P.K. Goon, E. Hanon, T. Igakura, Y. Tanaka, J.N. Weber, G.P. Taylor, and C.R. Bangham High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis Blood 99 2002 3335 3341
36. F. Toulza, K. Nosaka, Y. Tanaka, T. Schioppa, F. Balkwill, G.P. Taylor, and C.R. Bangham Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3 + regulatory T cells J Immunol 185 2010 183 189
37. F. Toulza, A. Heaps, Y. Tanaka, G.P. Taylor, and C.R. Bangham High frequency of CD4+FoxP3+cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response Blood 111 2008 5047 5053
38. Y. Yamano, N. Takenouchi, H.C. Li, U. Tomaru, K. Yao, C.W. Grant, D.A. Maric, and S. Jacobson Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease J Clin Invest 115 2005 1361 1368
39. N. Yamamoto-Taguchi, Y. Satou, P. Miyazato, K. Ohshima, M. Nakagawa, K. Katagiri, T. Kinashi, and M. Matsuoka HTLV-1 bZIP factor induces inflammation through labile Foxp3 expression PLoS Pathog 9 2013 e1003630
40. C.R. Bangham, F. Toulza, and T. Adult Cell leukemia/lymphoma: FoxP3(+) cells and the cell-mediated immune response to HTLV-1 Adv Cancer Res 111 2011 163 182
41. F. Toulza, K. Nosaka, M. Takiguchi, T. Pagliuca, H. Mitsuya, Y. Tanaka, G.P. Taylor, and C.R. Bangham FoxP3+ regulatory T cells are distinct from leukemia cells in HTLV-1-associated adult T-cell leukemia Int J Cancer 125 2009 2375 2382
42. M. Matsuoka, and J. Yasunaga Human T-cell leukemia virus type 1: replication, proliferation and propagation by Tax and HTLV-1 bZIP factor Curr Opin Virol 3 2013 684 691
43. G. Ma, J.-i. Yasunaga, H. Akari, and M. Matsuoka TCF1 and LEF1 act as T-cell intrinsic HTLV-1 antagonists by targeting Tax Proc Natl Acad Sci U S A 112 2015 2216 2221
44. H.J. Szerlong, J.E. Prenni, J.K. Nyborg, and J.C. Hansen Acitvator-dependent p300 acetylation of chromatin in vitro: Enhancement of transcription by disruption of repressive nucleosome-nucleosome interactions J Biol Chem 285 2010 31954 31964
45. S.A. Chevalier, J. Turpin, A. Cachat, P.V. Afonso, A. Gessain, J.N. Brady, C.A. Pise-Masison, and R. Hahieux Gem-induced cytoskeleton remodeling increases cellular migration of HTLV-1-infected cells, formation of infected-to-target T-cell conjugates and viral transmission PLoS Pathog 10 2014 e1003917
46. M. Matsuoka, and K.-T. Jeang Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ, and therapy Oncogene 30 2011 1379 1389
47. W.J. Grossman, J.T. Kimata, F.H. Wong, M. Zutter, T.J. Ley, and L. Ratner Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I Proc Natl Acad Sci U S A 92 1995 1057 1061
48. H. Hasegawa, H. Sawa, M.J. Lewis, Y. Orba, N. Sheehy, Y. Yamamoto, T. Ichinohe, Y. Tsunetsugu-Yokota, H. Katano, H. Takahashi, and et al. Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I Nat Med 12 2006 466 472
49. T. Ohsugi A transgenic mouse model of human T cell leukemia virus type 1-associated diseases Front Microbiol 4 2013 49
50. Y.B. Choi, and E.W. Harhaj HTLV-1 Tax stabilizes MCL-1 via TRAF6-dependent K63-linked polyubiquitination to promote cell survival and transformation PLoS Pathog 10 2014 e1004458
51. A. Lavorgna, M. Matsuoka, and Harhaj E.W. A critical role for IL-17RB signaling in HTLV-1 Tax-induced NFkB activation and T cell transformation PLoS Pathog 10 2014 e1004418
52. H.H. Baydoun, X.T. Bai, S. Shelton, and C. Nicot HTLV-1 tax increases genetic instability by inducing DNA double strand breaks during DNA replication and switching repair to NHEJ PLoS ONE 7 2012 e42226
53. D.Y. Jin, F. Spencer, and K.T. Jeang Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1 Cell 93 1998 81 91
54. S.S. Durkin, X. Guo, K.A. Fryrear, V.T. Mihaylova, S.K. Gupta, S.M. Belgnaoui, A. Haoudi, G.M. Kupfer, and O.J. Semmes HTLV-1 Tax oncoprotein subverts the cellular DNA damage response via binding to DNA-dependent protein kinase J Biol Chem 283 2008 36311 36320
55. S.Y. Kao, F.J. Lemonie, and S.J. Marriott Suppression of DNA repair by HTLV-I Tax is rescued by a functional p53 signaling pathway J Biol Chem 2000
56. M. Boxus, J.C. Twizere, S. Legros, R. Kettmann, and L. Willems Interaction of HTLV-1 Tax with minichromosome maintenance proteins accelerates the replication timing program Blood 119 2012 151 160
57. L. Zane, J. Yasunaga, Y. Miagami, V. Yedavalli, S.W. Tang, C.Y. Chen, L. Ratner, X. Lu, and K.T. Jeang Wip1 and p53 contribute to HTLV-1 Tax-induced tumorigenesis Retrovirology 9 2012 114
58. T. Kinoshita, M. Shimoyama, K. Tobinai, and et al. Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction Proc Natl Acad Sci U S A 86 1989 5620 5630
59. M. Matsuoka, and P.L. Green The HBZ gene, a key player in HTLV-1 pathogenesis Retrovirology 6 2009 71
60. Y. Satou, J. Yasunaga, T. Zhao, M. Yoshida, P. Miyazato, K. Takai, K. Shimizu, K. Ohshima, P.L. Green, N. Ohkura, and et al. HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo PLoS Pathog 7 2011 e1001117
61. Y. Satou, J. Yasunaga, M. Yoshida, and M. Matsuoka HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells Proc Natl Acad Sci U S A 103 2006 720 725
62. J. Arnold, B. Zimmerman, M. Li, M.D. Lairmore, and P.L. Green Human T-cell leukemia virus type-1 antisense-encoded gene Hbz, promotes T-lymphocyte proliferation Blood 112 2008 3788 3797
63. A.S. Kuhlmann, J. Villaudy, L. Gazzolo, M. Castellazzi, J.M. Mesnard, and M. Duc Dodon HTLV-1 HBZ cooperates with JunD to enhance transcription of the human telomerase reverse transcriptase gene (hTERT) Retrovirology 4 2007 92
64. J.-M. Mesnard, B. Barbeau, and C. Devaux HBZ, a new important player in the mystery of adult T-cell leukemia Blood 108 2006 3979 3982
65. T. Zhao, J. Yasunaga, Y. Satou, M. Nakao, M. Takahashi, M. Fujii, and M. Matsuoka Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-kappaB Blood 113 2009 2755 2764
66. H. Zhi, L. Yang, Y.L. Kuo, Y.K. Ho, H.M. Shih, and C.Z. Giam NF-kB hyperactivation by HTLV-1 tax induces cellular senescence, but can be alleviated by the viral anti-sense protein HBZ PLoS Pathog 7 2011 e1002480
67. G. Ma, J. Yasunaga, J. Fan, S. Yanagawa, and M. Matsuoka HTLV-1 bZIP factor dysregulates the Wnt pathways to support proliferation and migration of adult T-cell leukemia cells Oncogene 32 2013 4222 4230
68. E. Wattel, J.P. Vartanian, C. Pannetier, and S. Wain-Hobson Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy J Virol 69 1995 2863 2868
69. L.B. Cook, A.G. Rowan, A. Melamed, G.P. Taylor, and C.R. Bangham HTLV-1-infected T cells contain a single integrated provirus in natural infection Blood 120 2012 3488 3490
70. L.B. Cook, A. Melamed, H. Niederer, M. Valganon, D. Laydon, L. Foroni, G.P. Taylor, M. Matsuoka, and C.R. Bangham The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphoma Blood 123 2014 3925 3931
71. N.A. Gillet, N. Malani, A. Melamed, N. Gormley, R. Carter, D. Bentley, C. Berry, F.D. Bushman, G.P. Taylor, and C.R. Bangham The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones Blood 117 2011 3113 3122
72. A. Melamed, D.J. Laydon, N.A. Gillet, Y. Tanaka, G.P. Taylor, and C.R. Bangham Genome-wide determinants of proviral targeting clonal abundance and expression in natural HTLV-1 infection PLoS Pathog 9 2013 e1003271
73. D.J. Laydon, A. Melamed, A. Sim, N.A. Gillet, K. Sim, S. Darko, J.S. Kroll, D.C. Douek, D.A. Price, C.R. Bangham, and et al. Quantification of HTLV-1 clonality and TCR diversity PLoS Comput Biol 10 2014 e1003646
74. B. Asquith, Y. Zhang, A.J. Mosley, C.M. de Lara, D.L. Wallace, A. Worth, L. Kaftantzi, K. Meekings, G.E. Griffin, Y. Tanaka, and et al. In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection Proc Natl Acad Sci U S A 104 2007 8035 8040
75. C. Tomasetti, and B. Vogelstein Cancer etiology Variation in cancer risk among tissues can be explained by the number of stem cell divisions Science 347 2015 78 81
76. C.R. Bangham, L.B. Cook, and A. Melamed HTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infection Semin Cancer Biol 26C 2014 89 98
77. A. Melamed, A.D. Witkover, D.J. Laydon, R. Brown, K. Ladell, K. Miners, A.G. Rowan, N. Gormley, D.A. Price, G.P. Taylor, and et al. Clonality of HTLV-2 in natural infection PLoS Pathog 10 2014 e1004006
78. K. Tsukasaki, H. Tsushima, M. Yamamura, T. Hata, K. Murata, T. Maeda, S. Atogami, H. Sohda, S. Momita, S. Ideda, and et al. Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease Blood 89 1997 948 956
79. K. Tezuka, R. Xun, M. Tei, T. Ueno, M. Tanaka, N. Takenouchi, and J. Fujisawa An animal model of adult T-cell leukemia humanized mice with HTLV-1 specific immunity Blood 123 2014 255 346
80. J. Villaudy, M. Wencker, N. Gadot, J.-Y. Scoazec, L. Gazzolo, M.G. Manz, C.R. Bangham, and M. DucDodon HTLV-1 propels thymic human T cell development in 'human immune system' Rag2-/-IL-2Rgammac-/- mice PLoS Pathog 7 2011 e1002231
81. M. Saito, R. Tanaka, H. Fujii, A. Kodama, Y. Takahashi, T. Matsuzaki, H. Takashima, and Y. Tanaka The neutralizing function of the anti-HTLV-1 antibody is essential in preventing in vivo transmission of HTLV-1 to human T cells in NOD-SCID/inverted question markcnull (NOG) mice Retrovirology 11 2014 74
82. S.L. Maude, E.J. Shpall, and S.A. Grupp Chimeric antigen receptor T-cell therapy for ALL Hematology 2014 559 564
83. M.A. Postow, M.K. Callahan, and J.D. Wolchok Immune checkpoint blockade in cancer therapy J Clin Oncol 33 2015 1974 1982
84. N.A. Gillet, L. Cook, D.J. Laydon, C. Hlela, K. Verdonck, C. Alvarez, E. Gotuzzo, D. Clark, L. Farre, A. Bittencourt, and et al. Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo PLoS Pathog 9 2013 e1003263
85. B. Vogelstein, N. Papadopoulos, V.E. Velculescu, S. Zhou, L.A. Diaz Jr., and K.W. Kinzler Cancer genome landscapes Science 339 2013 1546 1558
86. K. Kataoka, Y. Nagata, A. Kitanaka, Y. Totoki, J.-i. Yasunaga, S. Kotani, A. Sato-Otsubo, M. Sanada, Y. Shiraishi, T. Shimamamura, and et al. Landscape of Genetic Alterations in Adult T-cell Leukemia/Lymphoma 2014 American Society for Hematology San Francisco p. 75